India Says Counterfeit Drugs Should Be Handled By WTO - Not WHO
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Years of strong opposition from the Indian government, bolstered by recent support in that effort by some Latin American, African and South-East Asian countries, has exerted pressure on the World Health Assembly to establish a working group to handle the controversy surrounding the definition of "substandard" and "counterfeit" drugs